<?xml version="1.0"?>
<oembed><version>1.0</version><provider_name>KFF Health News</provider_name><provider_url>https://kffhealthnews.org</provider_url><author_name>brilabuskes</author_name><author_url>https://kffhealthnews.org/news/author/brilabuskes/</author_url><title>Pharma Companies Have Infiltrated Process That Determines How Their Drugs Are Covered By Taxpayers - KFF Health News</title><type>rich</type><width>600</width><height>338</height><html>&lt;blockquote class="wp-embedded-content" data-secret="QUEyH8b5Lh"&gt;&lt;a href="https://kffhealthnews.org/morning-breakout/pharma-companies-have-infiltrated-process-that-determines-how-their-drugs-are-covered-by-taxpayers/"&gt;Pharma Companies Have Infiltrated Process That Determines How Their Drugs Are Covered By Taxpayers&lt;/a&gt;&lt;/blockquote&gt;&lt;iframe sandbox="allow-scripts" security="restricted" src="https://kffhealthnews.org/morning-breakout/pharma-companies-have-infiltrated-process-that-determines-how-their-drugs-are-covered-by-taxpayers/embed/#?secret=QUEyH8b5Lh" width="600" height="338" title="&#x201C;Pharma Companies Have Infiltrated Process That Determines How Their Drugs Are Covered By Taxpayers&#x201D; &#x2014; KFF Health News" data-secret="QUEyH8b5Lh" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"&gt;&lt;/iframe&gt;&lt;script type="text/javascript"&gt;
/* &lt;![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&amp;&amp;d.addEventListener&amp;&amp;"undefined"!=typeof URL&amp;&amp;(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&amp;&amp;!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i&lt;o.length;i++)o[i].style.display="none";for(i=0;i&lt;a.length;i++)s=a[i],e.source===s.contentWindow&amp;&amp;(s.removeAttribute("style"),"height"===t.message?(1e3&lt;(r=parseInt(t.value,10))?r=1e3:~~r&lt;200&amp;&amp;(r=200),s.height=r):"link"===t.message&amp;&amp;(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&amp;&amp;n.host===r.host&amp;&amp;l.activeElement===s&amp;&amp;(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r&lt;s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
/* ]]&gt; */
&lt;/script&gt;
</html><description>An investigation by NPR and the Center for Public Integrity looks at the brazen and sometimes illegal steps the companies take to get their medication on Medicaid's "preferred drug lists." In other pharmaceutical news: FDA Chief Scott Gottlieb blasts drugmakers for blocking development of biosimilars; the White House is reviewing a plan to curb drug rebates; a Senate panel will vote on "gag clauses" next week; and more.</description></oembed>
